Marlex mesh interposition as part of staged abdominal repair (M-STAR) was used on 68 occasions to reduce pressure during abdominal closure (46), facilitate multiple laparotomies (15), both indications (4) or defect repair (3), in 66 critical care admissions (median APACHE-II=21). Physiological data before and after M-STAR performed for intra-abdominal pressure were retrospectively available on 33/36 ventilated occasions. Compliance improved (median Vt/[Paw-PEEP] 22.6 vs 30.3 ml/cm H 2 O, P<0.0001), but efficiency of oxygenation (median P a O 2 /FiO 2 136 vs 175 mmHg) and ventilation (median VE/P a CO 2 243 vs 289 ml/min/mmHg) were unchanged. Heart rate fell (median 130 to 110, P=0.01), blood pressure and inotrope dose did not change. Urine flow increased (median 60 to 110 ml/h, P=0.007) but there was no clear trend in six-hourly serum creatinine. Seven bowel fistulae and three dehiscences occurred. Thirty-five patients survived critical care after 2-7 (median 2) M-STAR related operations and 3-63 (median 20) days. Thirty-one hospital survivors used 19-158 (median 47) hospital days; one patient was still in hospital at 39 months. Five patients died 1-55 months after hospital discharge. At follow-up 1-39 (median 7.5) months after critical care there were two fistulae, five stitch sinuses and five incisional hernias in the 27 survivors. M-STAR facilitates critical care and repeat laparotomy with acceptable surgical sequelae.
Abdominal distension with raised intra-abdominal pressure (IAP) may be seen in the critically ill and injured due to such causes as intra-abdominal haemorrhage, bowel oedema, or ileus with massive gaseous distension. Acute elevation of IAP above 25cm H 2 0 is now recognized to adversely affect respiratory, cardiovascular and renal function [1] [2] [3] [4] [5] . Routine monitoring of IAP in all intensive care patients at risk has been recommended 4 to allow timely surgical decompression if required. If abdominal closure is difficult, interposition of Marlex mesh (Marlex synthetic mesh, CR Bard Inc, MA) is one method allowing temporary closure without tension. Although intraabdominal sepsis infrequently leads to raised IAP, Marlex mesh placement has often been used in this setting to facilitate repeated access [6] [7] [8] [9] [10] . Recently the term "staged abdominal repair" (STAR) has been suggested for planned multiple repeat laparotomies aided by temporary closure techniques avoiding raised IAP, culminating in final abdominal closure 11 . We have used Marlex mesh as part of staged abdominal repair (M-STAR) and this study reviews our clinical experience of the technique.
PATIENTS AND METHODS
The Department of Critical Care Medicine (DCCM) is a fourteen-bed adult general intensive care unit with a current annual admission rate of approximately 1000. All patients are managed by consensus by a team of full-time intensivists according to standard protocols 12 . All adult patients (15 years and older) who underwent M-STAR (as described in the Appendix) between 15/06/88 (the first patient) and 31/12/93, were identified from the DCCM database 12 . Information was obtained retrospectively from the DCCM database, discharge summary and 24-hour charts and the casenotes about diagnosis and severity (APACHE-II first 24 hours all patients 13 and Injury Severity Scores [ISS] 14, 15 for trauma), indication for M-STAR, physiological data before and after M-STAR, DCCM course, hospital course and surgical course including drain losses in the first 24 hours after M-STAR. Complications were ascertained from the hospital notes in those who had died and for the survivors a personal interview was attempted. Survivors were assessed at a surgical follow-up clinic 2-40 (median 9) months after critical care and 1-39 (median 7.5) months after hospital discharge. Twenty of the surviving twenty-seven patients, including the longterm inpatient were interviewed and examined, four were interviewed by phone only and in three cases information was gathered from the notes only (specific comment about the abdominal wound had been made in all three cases).
The physiological changes before and after M-STAR were analysed for significance using the Wilcoxon signed rank test and repeated measure analysis of variance for serum creatinine. Fisher's exact test was used to determine significance in contingency tables and the Mann-Whitney test for comparison of unpaired measures between groups.
Characteristics of 66 DCCM admissions (64 patients) who had M-STAR are shown in Table 1 . All had both ventilatory and inotropic support, 38 had intravenous nutrition, 34 had a tracheostomy and six were dialysed.
RESULTS
Characteristics of 68 initial M-STAR procedures are shown in Table 2 .
Acute physiologic changes
Of 50 episodes of M-STAR where raised IAP was an indication, there were 33 occasions when paired measures of oxygenation, ventilation, total thoracic compliance, haemodynamics, acid-base status and urine volume were available. Of the other 17 cases, 12 patients were admitted to DCCM after M-STAR, two patients were not ventilated prior to the procedure and data were missing on three occasions. Values of the paired physiological variable for the 33 patients are shown in Table 3 . For these 33 patients median serum creatinine was 0.11 mmol/l (range 0.04-0.48) six hours before M-STAR, 0.12 mmol/l (range 0.04-0.51) immediately before M-STAR and 0.13 mmol/l (range 0.05-0.49) six hours after M-STAR (no significant time-related change by repeated measures analysis of variance). If only the 17 patients who had a urine output of 60ml per hour or less are considered, there was a marked increase in urine output from 9-60, median 21 ml/h pre-M-STAR to 5-780, median 77 ml/h, P=0.004, but no significant change in median serum creatinine. There was no significant change in urine output in the group of 16 patients with urine output >60 ml/h (66-350, median 101 pre-M-STAR to 30-375, median 142 post-M-STAR).
Although measures of intra-abdominal (intravesical) pressure 4 prior to decompression (ranging from 16-69, median 30 cm H 2 O) were available in only 13/33 patients, there were no significant differences between these 13 and the other 20 in APACHE-II scores or in the measures (pre and post M-STAR) of P a O 2 /FiO2, VE/P a CO 2 , Vt/(Paw-PEEP), HR, MAP, inotrope infusion rate and urine output used in Table 3 .
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Clinical course and complications
Thirty-five patients survived 37 admissions to DCCM with a median length of stay of 20 days (range 3-63 days). There were 29 patients who died in DCCM, a median of five days (range 3 hours-32 days) after DCCM admission. Three other patients died before leaving hospital (two uncontrolled sepsis, one aortic anastomotic failure). Thirty-two patients died in hospital after a median hospital stay of eight days (range six hours to 50 days). Thirty-one patients survived 32 hospital admissions with a median length of hospital stay of 47 days (range 19-158 days). One patient has still not left hospital 39 months after admission. Twenty-three of 46 patients having M-STAR for elevated IAP alone died in hospital, as did five of 15 for whom repeated access was the only indication for M-STAR. At follow-up five patients had died 4-55 months after hospital discharge (carcinoma 3, intracranial haemorrhage 1, renal failure 1).
Surgical course
The median number of laparotomies was 3 (range 1-20) during 65 hospital admissions. Thirty-one hospital survivors underwent a median of two operative procedures (range 2-7) involving the mesh per admission including insertion, planned re-laparotomy, reduction and final abdominal closure.
Fluid losses from the mesh drains in the first 24 hours after insertion ranged from 200 to 4950 ml (median 1775 ml) on 56 occasions. One severely anaemic patient who refused blood products died two hours after M-STAR without blood loss. Four other patients died from uncontrollable haemorrhage 2-9 hours after laparotomy and blood loss in these patients averaged 2.5 litres per hour over this period. On six occasions no drains were placed and data on one occasion was missing.
Fistulae complicated M-STAR on seven occasions in six patients. Five fistulae were diagnosed around the time of mesh removal and two some days after mesh removal. Four fistulae were from small bowel alone, two from colon alone and one from both small bowel and colon and all became evident in DCCM. At follow-up only two patients still had bowel fistulae.
There were no dehiscences of the Marlex from the edge of the fascia. Three abdominal wound dehiscences occurred among the 42 wounds with primary fascial repair at definitive wound closure.
In the group of 27 patients who are current survivors, five have had an incisional hernia, one of which has been repaired.
Of 68 episodes of M-STAR, 26 patients died prior to mesh removal and in 42 cases the mesh was removed and fascia closed at a median of seven days (range 2-21 days). In 28 of these the skin was closed primarily, three were secondarily closed 2, 3 and 15 days after fascial closure and 11 were left to granulate. Six of 27 patients at follow-up had a history of stitch sinuses or extrusion of suture material. In only three of these was the original skin closure by granulation.
DISCUSSION
The severity of illness of our patients [13] [14] [15] was comparable or greater than that in other series 7, [16] [17] [18] . Organ failure was common and the desired physiologic goals were achieved only with difficulty despite an aggressive prophylactic style of treatment 12 .
Elevated IAP after trauma, aortic or liver surgery is usually due to bleeding and can often be relieved by evacuation of haematoma 1, 2, 19 and the abdomen then closed without excess IAP. Insertion of packs requires repeated access and will increase IAP because of the bulk of the packs. Some increase in IAP is desirable in this situation for the tamponade effect but in seven of 19 patients with packs abdominal closure without M-STAR was impossible (or produced excess IAP).
When elevated IAP occurs in sepsis, pancreatitis or bowel obstruction there may be ascites, accumulation of gut luminal fluid and visceral or retroperitoneal oedema. Closure without elevated IAP may be impossible without a STAR technique 16, 20 but in sepsis most authors have used this technique to facilitate repeat access rather than to reduce IAP. In comparison with most other reports [6] [7] [8] 10, 16, 19, 21 M-STAR was more frequently performed in our patients for raised IAP (50/68) and in more than half of these it was requested by intensivists often as a desperate measure in patients with severe respiratory failure and impending renal failure. The number of M-STAR procedures has risen markedly (15 during 1988-1991, 53 during 1992-1993) . Recently surgeons have been performing M-STAR for elevated IAP and ventilatory compromise at the time of first attempted closure and more frequently made this decision themselves in 1993 (29/38 vs 11/30, P=0.0001).
The pathophysiology of high IAP has been defined in laboratory and clinical studies which are wellreviewed by Ulyatt 4 and more recently by Schein 38 . Cardiac output is initially compromised mainly by decreased preload, but with even higher IAP it cannot readily be restored by volume loading and inotropic support because of an independent effect on ventricular dimensions and filling. The elevated diaphragm reduces thoracic compliance, pulmonary blood flow is redistributed and increased extravascular lung water contributes to the inefficiency of oxygenation and ventilation. Renal dysfunction is caused by direct parenchymal compression often aggravated by reduced cardiac output. Intense tubular resorption of sodium and water leads to oliguria. Consistent with this clinical syndrome our patients had severe respiratory failure affecting oxygenation (median P a O 2 /FiO 2 136 mm Hg), ventilation (median VE/P a CO 2 244 ml/min/mmHg) and total thoracic compliance (median Vt/[Paw-PEEP] 23 ml/cm H 2 O). Although compliance improved with M-STAR (allowing increase in tidal volume without increase in peak airway pressure) the efficiency of oxygenation and ventilation were not significantly improved. Similar changes in compliance in four patients (who also had improvement in oxygenation) after abdominal decompression were reported by Cullen 3 .
Most patients had metabolic acidosis (median pHa 7.30, BE -6) and tachycardia (median 130). Substantial inotropic support was often required to maintain MAP at required levels (90-110 mmHg). Although heart rate fell with M-STAR the level of inotropic support required to maintain the same MAP and the acid-base status did not change significantly. In studies of four 3 and three 22 patients decompression of the abdomen increased stroke volume and cardiac output and decreased elevated filling pressures but there was no change in cardiac output in 46 patients in a recent series 18 . Heart rate was unchanged in one study 3 and fell in another 22 . An associated fall in systemic vascular resistance and MAP was marked enough in two patients to require vasoconstrictors 22 . Asystole occurred immediately on decompression in four of fifteen trauma patients in a separate report 23 . None of our patients had a catastrophic fall in MAP but most were already on titrated inotropic support and had been aggressively volume loaded 12 .
The urine output rose substantially but there was no clear time-related change in serum creatinine over 12 hours around the time of M-STAR. The significant improvement in urine flow for the group as a whole was largely due to a marked increase in urine flow in most of the patients with urine flows of 60 ml/hour or less. Impressive improvement in urine flow in some patients (but not all) has been reported by other authors 3,18,24 but these authors did not report serum creatinine. Platell and colleagues 19, 25 showed that serum creatinine typically rose for 24-48 hours after decompression despite a diuresis. In many of our patients renal failure was multifactorial (sepsis, aminoglycosides, diabetes, previous shock and hypotension) and these factors are unaltered by decompression.
Intensive care stay in our M-STAR patients was very long in comparison with our total DCCM patient population. In 1993 median stay in DCCM was only two days for survivors and one day for non-survivors despite a low incidence of elective admissions and a high incidence of respiratory failure 12 . M-STAR patients who survived their critical care stay often had long periods of demanding wound care, repeated operative procedures, nutritional support, convalescence and rehabilitation in surgical wards. Our hospital mortality for M-STAR of 49% (32 deaths out of 65 hospital admissions) is high compared with our overall 18% hospital mortality for DCCM admissions 12 but reflects severity of illness. Twenty-five M-STAR patients fulfilled criteria for septic shock 26 . Mean APACHE-II score predicted mortality was 46% (95% CI 41-52%). Many authors 1, 3, 18, 19, 22, 27 have reported very high mortality in small series of patients having decompression for elevated intra-abdominal pressure-overall 35 of the 72 patients in these six series died. Smith and co-workers 16 reported only four deaths in sixteen trauma patients having decompression but thirteen of these patients had penetrating trauma and median ISS (probably using the 1985 AIS revision) was 25. In our series of fifteen trauma patients there were six deaths, but our patients were more severely injured (median ISS 34) and all but one had blunt trauma. In a larger series of trauma patients similar to ours in severity, mortality was 41% 18 . Mortality in patients having M-STAR for repeated access may be a little lower; a review by Schein 28 of 15 studies involving in total 383 such patients revealed a 37% hospital mortality, similar to our own. Late deaths reflected underlying disease and were unrelated to M-STAR.
No prospective controlled trial of STAR techniques has been reported. In an uncontrolled prospective study of STAR in 117 patients with advanced, diffuse peritonitis, Wittman et al 7 found that mortality (24%) was significantly lower (P=0.012, Fishers exact test) than that predicted by APACHE-II scoring (39%), but commented on the limitations of this approach in establishing therapeutic benefit. A similar fundamental objection to this approach, to which we also subscribe, has been expressed by Chang and Bihari 29 . Sugrue and colleagues 41 found that the presence of elevated IAP greatly increased mortality risk (odds ratio 11.2, 95% confidence limits 2.8-47.9) in a group of surgical patients (median APACHE-II 13.5, range 4-43) but unfortunately APACHE-II scores were not presented separately for the patients with and without increased STAGED ABDOMINAL REPAIR IN CRITICAL ILLNESS Anaesthesia and Intensive Care, Vol. 24, No. 3, June 1996 IAP. We note that APACHE-II has been shown to underestimate mortality in two other populations with independent risk factors, exogenous corticosteroid administration 42 or HIV-positivity 39 . We agree with the editorial view 40 to the latter paper that this reflects the likelihood that the "early clinical populations used to refine APACHE were not likely to have contained significant numbers of patients with AIDS" and suggest that similar considerations pertain to elevated IAP.
Re-laparotomy through the mesh (as described in the Appendix) avoids repeated trauma to the fascia and may increase the likelihood of successful primary closure without dehiscence. We doubt that the features of zippers or Velcro for repeated access offer real advantage over incision of the mesh and resuturing (which also allows partial closure if IAP permits).
Fluid losses from the drains between the Marlex mesh and the transparent dressing were significant but measurable and controlled, and were replaced with colloid if appropriate 30 . Where an adequate seal cannot be maintained (and gauze dressings are used over the mesh), fluid and dressing management is more difficult. Although coagulopathic bleeding in the presence of high IAP is very problematic (and often not salvageable) M-STAR may allow the patient to be ventilated whilst preserving some tamponade during coagulation correction.
Our rate of fistula formation (9%) was low and may be decreasing-five fistulae occurred in our first 30 M-STAR and only two in the 38 M-STAR in 1993. Jones and Jurkovich 31 reported a fistula rate of 23% in a review of 14 series of polypropylene mesh use in the emergency setting (total 128 patients). More recent reports 20, 32, 33 suggest an incidence of 10-13%. Avoidance of fistula formation is of great importance because of the high mortality of this complication 34, 35 . As fistulae were more common (5/19 vs 2/49, P=0. 016 Fisher's exact test) in patients where intra-abdominal packing was used, we recommend meticulous care in the insertion and removal of packs. If the mesh is not removed there is a risk of late mesh extrusion, predisposing to fistula formation. Prior to the use of prosthetic mesh the incidence of fistulae in "open abdomen" treatment was prohibitive 33 , probably due in part to the exposure of distended gut to atmospheric pressure 11 . Where no prosthesis is used (or where a mesh is not covered by a transparent dressing), trauma may be produced to the underlying bowel during the necessary frequent changes of gauze, especially if they have been allowed to dry. The use of any prosthesis provides some counterpressure across the bowel wall. Although many dif-ferent prostheses (e.g. prolene, PTFE, polyglycolic acid) have been used there is no clear evidence of superiority of one method over another 20 .
The rate of dehiscence (3/42) on definitive abdominal fascial closure compares with a general laparotomy dehiscence rate of less than 1%, but many of our patients had known risk factors for dehiscence including raised IAP, wound infection, advanced age or malnutrition 36 . Abdominal wall blood flow is markedly reduced by modest elevation of IAP to levels which may reduce wound healing and predispose to wound breakdown 37 . Avoidance of excessive tension with closure is emphasized by other authors 21 .
The incidence of incisional hernias in our series is also low. Patients treated with "open abdomen" where polypropylene mesh is removed will (without fascial closure) usually have abdominal hernias 20 as will most patients who have polyglycolic acid mesh left in situ 32 . Fabian et al accept a high short-term rate of hernias in avoiding the problem of primary fascial closure, but many of these end up being permanent. Planned secondary hernia repair is difficult and requires either permanent mesh insertion or extensive mobilization of skin and fascia. Fabian reported results of such repair in 22 patients; five had further infection and five had hernia recurrence. Of note, a further 12 patients were lost to follow-up and 12 were not ready for reconstruction. We agree with Schein that primary closure of the abdomen should be done wherever possible 21 . There were a small number of suture extrusions in our patients, none of which caused a major problem.
We conclude that M-STAR facilitates critical care and repeat laparotomy for selected patients with elevated IAP, a need for repeated access or abdominal wall defects with acceptable mortality and surgical sequelae.
ADDENDUM
Since the preparation of this report, the longterm inpatient (who had fistula at followup) died after 42 months in hospital.
APPENDIX: M-STAR technique and nursing care.
Our technique is adapted from that described by Schein 27 . For maximal decompression in midline incisions an extension from xiphisternum to symphysis pubis is recommended; a bilateral subcostal incision has proved very satisfactory for pancreatitis. Bowel is covered with omentum if possible and stomas are sited well clear of the skin edge. A single large sheet of Marlex mesh is shaped to match the deficit and sutured to the edge of the deepest fascial layer (linea alba in midline incisions, posterior rectus sheath otherwise) using a monofilament nylon in a continuous running suture. Large Redivac drains (14 gauge) are placed on top of the mesh and brought out through separate stab incisions preferably 5cm or more from the skin edge. The skin is thoroughly cleaned, dried and then painted with tincture of Benzoin. A large sheet of adhesive transparent dressing is then placed over the whole abdomen, sealing off the mesh, and the drains are put on sufficiently high continuous suction (100-200 mmHg) to prevent accumulation of fluid between the mesh and the dressing. Meticulous nursing care is required to maintain this suction and to measure drain losses. Perforation of the dressing causes an audible hiss and visible loss of adhesion between the dressing and mesh. Small leaks can often be patched with a small dressing but if the leak is large the large dressing is replaced at the bedside under sterile conditions. Drains blocked by blood or fibrin clots are sometimes cleared by gentle flushing with saline but more often are replaced and a new dressing applied. Relaparotomy is performed through an incision in the mesh. This avoids repeated trauma to the fascia. Eventual mesh removal and primary fascial closure sometimes requires a staged procedure. The timing of reduction and removal is judged clinically once causes of raised IAP have resolved and the wound edges are able to be approximated somewhat with firm bimanual traction at the bedside. This is assessed during a period of adequate relaxation which requires analgesia and sometimes muscle relaxants. Reduction is achieved by removing a section of mesh and suturing the mesh on itself. Several procedures two to five days apart are sometimes necessary before closure, but separation of the mesh from granulation tissue is more difficult after about a week. If the mesh is thought likely to need to stay longer than a week, a sheet of plastic is placed over the viscera at the time of mesh insertion or revision which may ease removal of the mesh. Great care is taken when teasing the mesh from the viscera. A full laparotomy is not always performed; if there is no concern about intra-abdominal sepsis or bleeding the abdominal wall is simply freed from the viscera and closed in a routine fashion. Skin is closed as a primary procedure (in most cases) or a few days after fascial closure if wound infection is likely.
Pain is usually more severe and prolonged than after routine laparotomy. Patients require individually titrated analgesia and sedation. Patients and their relatives require explanation and support in coming to terms with a drastic alteration in body image.
